1. Home
  2. HIT vs QNCX Comparison

HIT vs QNCX Comparison

Compare HIT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIT
  • QNCX
  • Stock Information
  • Founded
  • HIT 1964
  • QNCX 2012
  • Country
  • HIT United States
  • QNCX United States
  • Employees
  • HIT N/A
  • QNCX N/A
  • Industry
  • HIT Specialty Insurers
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HIT Finance
  • QNCX Health Care
  • Exchange
  • HIT Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • HIT 38.2M
  • QNCX 44.0M
  • IPO Year
  • HIT 2024
  • QNCX 2019
  • Fundamental
  • Price
  • HIT $0.65
  • QNCX $1.04
  • Analyst Decision
  • HIT
  • QNCX Strong Buy
  • Analyst Count
  • HIT 0
  • QNCX 5
  • Target Price
  • HIT N/A
  • QNCX $8.00
  • AVG Volume (30 Days)
  • HIT 857.6K
  • QNCX 128.6K
  • Earning Date
  • HIT 04-14-2025
  • QNCX 05-12-2025
  • Dividend Yield
  • HIT N/A
  • QNCX N/A
  • EPS Growth
  • HIT N/A
  • QNCX N/A
  • EPS
  • HIT 0.02
  • QNCX N/A
  • Revenue
  • HIT $22,380,959.00
  • QNCX N/A
  • Revenue This Year
  • HIT $119,032.48
  • QNCX N/A
  • Revenue Next Year
  • HIT N/A
  • QNCX N/A
  • P/E Ratio
  • HIT $37.15
  • QNCX N/A
  • Revenue Growth
  • HIT 11.24
  • QNCX N/A
  • 52 Week Low
  • HIT $0.51
  • QNCX $0.51
  • 52 Week High
  • HIT $7.59
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • HIT N/A
  • QNCX 35.61
  • Support Level
  • HIT N/A
  • QNCX $0.97
  • Resistance Level
  • HIT N/A
  • QNCX $1.10
  • Average True Range (ATR)
  • HIT 0.00
  • QNCX 0.09
  • MACD
  • HIT 0.00
  • QNCX 0.01
  • Stochastic Oscillator
  • HIT 0.00
  • QNCX 29.91

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: